General
Preferred name
BIIB021
Synonyms
BIIB 021 ()
BIIB-021 ()
CNF2024 ()
CNF 2024 ()
94M ()
cpd 20 ()
CNF-2024 ()
Cnf2024 ()
P&D ID
PD011103
CAS
848695-25-0
Tags
available
drug candidate
probe
Drug indication
Breast cancer
Drug Status
investigational
Max Phase
Phase 2
Probe info
Probe type
experimental probe
Probe targets
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION This reference looks at the specificity of HSP90 inhibitors . BIIB021 exhibits antitumour activity in preclinical models, has maximum (2nM) potency against HSP90α (HSP90AA1) but cross-reacts between the four paralogues tested . (GtoPdb)
DESCRIPTION This reference looks at the specificity of HSP90 inhibitors . BIIB021, that exhibits antitumour activity in preclinical models, has maximum (2nM) potency against HSP90α (HSP90AA1) but cross-reacts between the four paralogues tested .
MOA Inhibitor (Chemical Probes.org)
DESCRIPTION Selective Hsp90 inhibitor (Tocriscreen Plus)
DESCRIPTION DNA alkylating agent; cytotoxic and antineoplastic (Tocris Bioactive Compound Library)
Cell lines
12
Organisms
0
Compound Sets
17
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Chemical Probes.org
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
High-quality chemical probes
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
External IDs
28
Properties
(calculated by RDKit )
Molecular Weight
318.1
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
3
cLogP
2.13
TPSA
91.74
Fraction CSP3
0.29
Chiral centers
0.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Cell Biology
Pathway
Cytoskeletal Signaling
Metabolism
Autophagy
Cell Cycle/DNA Damage
Metabolic Enzyme/Protease
Target
HSP90
HSP90AA1
HSP90 inhibitor
HSP
HSP (HSP90)
HSP90AA1, HSP90AB1
Primary Target
Hsp90
MOA
Inhibitor
HSP inhibitor
Orthogonal probe
Onalespib
Target subclass
Chaperone
Chaperone, Chaperone
Target class
Other post-translational modification
Other post-translational modification, Other post-translational modification
Source data